AA
ALNY icon

Alta Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History

Alta Advisers’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-557
Closed -$221K – 208
2025
Q4 		$221K Sell
557
-200
-26% -$88.5K 0.08% 177
2025
Q3 		$345K Hold
757
– – 0.11% 158
2025
Q2 		$247K Hold
757
– – 0.09% 199
2025
Q1 		$204K Buy
+757
New +$195K 0.09% 224
2024
Q4 		– Sell
-400
Closed -$110K – 164
2024
Q3 		$110K Hold
400
– – 0.05% 273
2024
Q2 		$97.2K Hold
400
– – 0.05% 269
2024
Q1 		$59.8K Hold
400
– – 0.03% 369
2023
Q4 		$76.6K Hold
400
– – 0.04% 315
2023
Q3 		$70.8K Hold
400
– – 0.04% 310
2023
Q2 		$76K Hold
400
– – 0.04% 311
2023
Q1 		$80.1K Hold
400
– – 0.05% 293
2022
Q4 		$95K Hold
400
– – 0.06% 237
2022
Q3 		$80K Buy
+400
New +$76.3K 0.05% 258

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return